SCHEMBL3276763

SCHEMBL3276763

CCOC(=O)c1c(CNS(C)(=O)=O)c2ccccc2n1Cc1cccc2ccc(F)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
POLB P06746 1/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NOD2 Q9HC29 1/20 0.40
NOD1 Q9Y239 1/20 0.40
TP53 P04637 2/20 0.40
ELANE P08246 3/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.39
S1PR3 Q99500 1/20 0.37
PER2 O15055 2/20 0.37
CRY1 Q16526 2/20 0.37
CRY2 Q49AN0 2/20 0.37
MCL1 Q07820 1/20 0.37
CDC25B P30305 1/20 0.37
F10 P00742 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3275034 0.95 MEN1 (0.44) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL3282760 0.90 KMT2A (0.52) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL3276222 0.90 MEN1 (0.50) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL3275938 0.88 POLB (0.53) MEN1KMT2APOLBMAPTTP53
SCHEMBL3276283 0.88 MEN1 (0.47) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL3276470 0.88 MEN1 (0.49) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL3281145 0.87 MEN1 (0.51) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL3277223 0.87 KMT2A (0.53) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL3275053 0.86 MEN1 (0.50) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL3283733 0.86 MEN1 (0.45) MEN1KMT2APOLBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966134-B1 NOVEL FUSED PYRROLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-12 EP disclosed
US-7696240-B2 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. (US) 2010-04-13 US disclosed
EP-1966134-A1 NOVEL FUSED PYRROLE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-09-10 EP disclosed
WO-2007068621-A1 NOVEL FUSED PYRROLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-06-21 WO disclosed
US-20070142452-A1 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142452-A1 Fused pyrrole derivatives CMA1, PREP, CPA3 MEN1 2461/4885KMT2A 3786/4885POLB 1631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.